Tag: transparency

No Doubt About It: Sunshine Reporting Will Draw Interest

Since the introduction of the Sunshine Act legislation several years ago, one question has been whether transparency will impact relationships between pharmaceutical and medical device manufacturers and health care providers and entities.  Others have wondered whether patients, enforcement authorities and the public at large will be interested in the reported data.  While these […]

TIME IS UP! Sunshine Data Tracking Starts Today

The day long awaited by the health care industry has finally arrived.  Today is the day that pharmaceutical, biotechnology and medical device manufacturers and group purchasing organizations (GPOs) must begin tracking payments and other transfers of value provided to “covered recipients” in accordance with Section 6002 of the Affordable Care Act (commonly […]

Additional Transparency for Clinical Trials Announced by Industry Groups

On July 24, 2013, the Pharmaceutical Research and Manufacturers of America (PhRMA) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) announced joint endorsement of the “Principles for Responsible Clinical Trial Data Sharing: Our Commitment to Patients and Researchers.”  These principles applicable to biopharmaceutical companies take effect January 1, […]

CMS Publishes FAQs for OPEN PAYMENTS Mobile Apps for Physicians & Industry

As we noted last week, CMS released two mobile apps for tracking reportable payments: one for physicians and one for applicable manufacturers and applicable GPOs. Both are available for download now for iOS (Apple™) and Android™ mobile phones.  New FAQs from CMS provide additional visibility into how CMS envisions physicians and industry using these […]

Sunshine in Your Pocket: CMS Releases Mobile Apps for Tracking and Reviewing OPEN PAYMENTS Data

Industry and physicians preparing to comply with federal sunshine provisions have a new resource available. To facilitate tracking and reviewing OPEN PAYMENTS Data, CMS has released two mobile applications (apps): one for physicians and one for applicable manufacturers and applicable GPOs. Use of the apps is optional and both are available […]

No Relief in Minnesota from Reporting Obligations

On June 24, 2013, the Minnesota Board of Pharmacy posted a letter to pharmaceutical manufacturers and drug wholesalers informing them that the Board’s request to the Minnesota legislature to repeal Minnesota Stat. §151.47(1)(f) did not occur. Rather, the Minnesota legislature modified the statute related to reporting obligations. The Minnesota Board […]

Available Now: CMS Templates for Data Collection and Reporting Under the Federal Sunshine Provisions

As the health care industry prepares for data collection beginning August 1, 2013, in accordance with the federal sunshine provisions in Section 6002 of the Affordable Care Act and its implementing regulations, industry must also plan ahead for reporting the data collected. Data collection and reporting are inextricably linked, as […]